1. Johnson, J., Canning, J., Kaneko, T., Pru, J. K., & Tilly, J. L. (2004). Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature, 428(6979), 145-150.
  2. Bukovsky, A., Caudle, M. R., Gupta, S. K., Svetlikova, M., Selleck-White, R., Ayala, A. M., & Dominguez, R. (2008). Mammalian neo-oogenesis and expression of meiosis-specific protein SCP3 in adult human and monkey ovaries. Cell Cycle, 7(5), 683-686.
  3. Sánchez, F., & Smitz, J. (2012). Molecular control of oogenesis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1822(12), 1896-1912.
  4. Moniruzzaman, M., & Miyano, T. (2010). Growth of primordial oocytes in neonatal and adult mammals. Journal of Reproduction and Development, 56(6), 559-566.
  5. López-Alarcón, M., Rodríguez-Cruz, M., Vital-Reyes, V. S., Zavala-Ortega, M. I., Hinojosa-Cruz, J. C., Canizales-Quinteros, S., & Fernández, J. (2012). PPARγ2 Pro12Ala polymorphism is associated with improved lipoprotein lipase functioning in adipose tissue of insulin resistant obese women. Gene, 511(2), 404-410.
  6. Virant‐Klun, I., Zech, N., Rožman, P., Vogler, A., Cvjetičanin, B., Klemenc, P. & Meden‐Vrtovec, H. (2008). Putative stem cells with an embryonic character isolated from the ovarian surface epithelium of women with no naturally present follicles and oocytes. Differentiation, 76(8), 843-856.
  7. Gougeon, A. (1996). Regulation of ovarian follicular development in primates: facts and hypotheses. Endocrine reviews, 17(2), 121-155.
  8. Baird, D. A. L. C. D. D. (2006). Role of FSH and LH in follicle development. Journal de Gynecologie Obstetrique et Biologie de la Reproduction, 35(5P2), 24-29.
  9. Reyes, V. S. V., Velasco, S. T., Castillo, B. R., Buenfil, M. B., & Cruz, J. C. H. (2012). Sensibilidad a la insulina en pacientes con falta de respuesta a la inducción de ovulación con citrato de clomifeno. Ginecol Obstet Mex, 80(7), 454-460.
  10. Kerr, J. B., Myers, M., & Anderson, R. A. (2013). The dynamics of the primordial follicle reserve. Reproduction, 146(6), R205-R215.


  1. Cheung, T. H., Lo, K. W. K., Lam, C. W. K., Lau, W. C., & Lam, P. K. W. (2000). A crossover study of triptorelin and leuprorelin acetate. Fertility and sterility, 74(2), 299-305.
  2. Wong, A. Y. K., & Tang, L. (2004). An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis. Fertility and sterility, 81(6), 1522-1527.
  3. Giudice, L. C. (2010). Endometriosis. New England Journal of Medicine, 362(25), 2389-2398.
  4. Filicori, M. A. R. C. O., Flamigni, C. A. R. L. O., Cognigni, G. R. A. C. I. E. L. A., Dellai, P. A. T. R. I. Z. I. A., Arnone, R. O. S. S. E. L. L. A., Falbo, A. N. G. E. L. A., & Capelli, M. A. U. R. I. Z. I. O. (1993). Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. The Journal of Clinical Endocrinology & Metabolism, 77(1), 130-133.
  5. Bergqvist, A., Bergh, T., Hogström, L., Mattsson, S., Nordenskjöld, F., & Rasmussen, C. (1998). Effects of triptorelin versus placebo on the symptoms of endometriosis. Fertility and sterility, 69(4), 702-708.
  6. Kang, J. L., Wang, X. X., Nie, M. L., & Huang, X. H. (2010). Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecologic and obstetric investigation, 69(2), 73.
  7. Dunselman, G. A. J., Vermeulen, N., Becker, C., Calhaz-Jorge, C., D’Hooghe, T., De Bie, B., & Nelen, W. (2014). ESHRE guideline: management of women with endometriosis. Human Reproduction, 29(3), 400-412.
  8. Brown, J., Pan, A., & Hart, R. J. (2010). Gonadotrophin‐releasing hormone analogues for pain associated with endometriosis. The Cochrane Library.
  9. Bhattacharya, S. M. (2009). Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause. Gynecological Endocrinology, 25(9), 621-623.
  10. Saucedo-de la Llata, E., Moraga, R., Díaz, P., Batiza, V., Galache, P., Santos, R., & Hernández-Ayup, S. Influencia de la endometriosis en un programa de Reproduccion Asistida.
  11. Leyland, N., Casper, R., Laberge, P., & Singh, S. S. (2010). Endometriosis: diagnosis and management. Journal of obstetrics and gynaecology Canada: JOGC= Journal d’obstetrique et gynecologie du Canada: JOGC, 32(7 Suppl 2), S1-32.
  12. Choktanasiri, W., Boonkasemsanti, W., Sittisomwong, T., Kunathikom, S., Suksompong, S., Udomsubpayakul, U., & Rojanasakul, A. (1996). Long-acting triptorelin for the treatment of endometriosis. International Journal of Gynecology & Obstetrics, 54(3), 237-243.
  14. Garcia-Velasco, J. A., & Quea, G. (2005). Medical treatment of endometriosis. Minerva ginecologica, 57(3), 249-255.